Detailed answers about SYMORPHIC MEDICAL TECHNOLOGIES LTD, including incorporation, status, business activity, and accounts information.
When was SYMORPHIC MEDICAL TECHNOLOGIES LTD founded?
SYMORPHIC MEDICAL TECHNOLOGIES LTD was officially incorporated on 28 April 2026 and is registered under company number 17186987. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is SYMORPHIC MEDICAL TECHNOLOGIES LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of SYMORPHIC MEDICAL TECHNOLOGIES LTD?
SYMORPHIC MEDICAL TECHNOLOGIES LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does SYMORPHIC MEDICAL TECHNOLOGIES LTD do?
SYMORPHIC MEDICAL TECHNOLOGIES LTD operates in the following sectors: 47789 - Other retail sale of new goods in specialised stores (not commercial art galleries and opticians), 47910 - Retail sale via mail order houses or via Internet, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is SYMORPHIC MEDICAL TECHNOLOGIES LTD's registered address?
The registered office address of SYMORPHIC MEDICAL TECHNOLOGIES LTD is 25 Galton Road, Cambridge, England, CB3 0YW. This is the official address filed with Companies House for legal and statutory correspondence.
Is SYMORPHIC MEDICAL TECHNOLOGIES LTD financially stable?
Financial accounts for SYMORPHIC MEDICAL TECHNOLOGIES LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.